Gastroenterology Information Center Archive
Patients with irritable bowel syndrome found FODMAP more beneficial than general dietary advice
The meta-analysis showed that short-term probiotic supplementation reduced body weight, BMI, and fat percentage, but the effect sizes were small.
The data suggest possible variability across NOACs regarding gastrointestinal bleeding risk, with an increased risk associated with rivaroxaban and dabigatran.
The researchers found that patients receiving adjuvant chemotherapy for gastroesophageal adenocarcinoma were younger, more likely to have advanced disease, and had shorter postoperative inpatient stays.
The association is partially mediated by levels of anxiety and depressive symptoms.
Patient-level interventions include changes to invitation, giving results or follow-up appointments, and patient navigators, and provider-level interventions include reminders or performance data.
The 12-year results show that Roux-en-Y gastric bypass offered long-term durability of weight loss and was associated with fewer obesity-related coexisting conditions compared with those who did not have the surgery.
Patients with childhood-onset IBD have an increased risk of cancer, especially gastrointestinal cancers, lymphoid neoplasms, and skin cancer,
A PEG low-volume regimen is similar to a PEG high-volume regimen for colon cleansing in patients with IBS.
Incidence of pneumonia was higher among patients with GERD compared with matched controls.
Clinical pathway to improve care of acute gastroenteritis patients is associated with a sustained reduction in IV fluid use and length of stay in the pediatric emergency department.
Asthma was associated with Crohn's disease and with early- and late-onset ulcerative colitis.
Researchers analyzed colorectal cancer mortality rates among individuals between 20 and 54 years of age from 1970 through 2014.
The addition of oats to a gluten-free diet did not affect symptoms, histology, immunity, or serologic features in patients with celiac disease.
Environmental risk factors that predispose people to inflammatory bowel disease may have a stronger effect in children than adults.
Researchers found that a cash incentive of $100 was associated with increased colorectal screening rates in eligible adults.
Many adverse events could be avoidable with more judicious use of antibiotics.
Serum TG2A screening has a positive predictive value of 61% to detect celiac disease.
An increased ADR is associated with an adjusted hazard ratio of 0.63 for interval colorectal cancer and 0.50 for cancer death.
Interferon- concentrations and THELPER cells are significantly reduced during symptom flares.
Risk of death is increased among those without gastrointestinal conditions and with prolonged use.
The score could help predict advanced colorectal neoplasia in adults younger than 50 years of age.
The guideline is intended to be an educational device to provide information that may assist endoscopists in providing care to patients.
Findings show that bacteria from mothers' breast milk and areolar skin are transferred to their infants' guts.
The new device uses magnetic catheters to draw the upper and lower esophagus together.
However, duodenal integrity appears to not be affected in eosinophilic esophagitis.
Gluten-rich food may lead to symptom onset, specifically early satiety, in patients with functional dyspepsia.
Treatment was effective in patients under 6 years who received 50 mg/day of zinc as an initial dose.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
Avoiding gluten may result in reduced consumption of beneficial whole grains that could affect cardiovascular risk.
A follow-up colonoscopy more than 10 months after a positive FIT result is associated with a higher risk of colorectal cancer and more advanced disease at the time of diagnosis.
Increasing duration of antibiotic use at ages 20 to 39 and 40 to 59 is significantly associated with an increased risk of colorectal adenoma.
Apixaban is associated with a lower risk of gastrointestinal bleeding than rivaroxaban or dabigatran.
Celiac disease is associated with anorexia nervosa before and after a diagnosis of celiac disease.
The test will provide information on an individual's genetic predisposition to 10 diseases or conditions.
The USPSTF evaluated the benefits and harms of screening vs not screening, targeted vs universal screening, and treatment for celiac disease.
A meta-analysis suggests that patients who take gastric acid suppressants may have a higher risk for recurrent CDI.
Researchers identified 5 factors that identify patients with IBD at high risk for hospitalization, emergency department visits, and high treatment charges in the next year.
Octogenarians with colorectal cancer have several differences in clinical and tumor characteristics, compared with younger patients with the disease.
Budesonide oral suspension treatment improved symptomatic, endoscopic, and histologic parameters in eosinophilic esophagitis.
The FDA has received 120 reports of serious cases of pancreatitis or death after the approval of Viberzi in May 2015.
Excess weight could influence the risk of of gastrointestinal cancers by altering insulin levels and promoting inflammation.
Implementation of the FODMAP diet is an effective strategy to manage symptoms of IBS, including bloating and abdominal pain.
Thirty-eight of 231 NCGS patients showed gluten-specific symptoms when completing the placebo-controlled gluten challenge.
Individuals who consume the least amount of gluten are more likely to develop type 2 diabetes.
The American College of Gastroenterology has released recommendations of preferred approaches for diagnosing and evaluating patients with abnormal liver test results.
Among GERD patients, the mean annual ARI episode dropped from 4.39 during the year before PPI treatment to 3.89 after treatment with a PPI.
Trulance has been approved for the treatment of chronic idiopathic constipation in adults.
The procedure could be used as alternative to bariatric surgery for selected patients with obesity.
Diabetes could increase the risk of developing hepatocellular carcinoma in patients with hepatitis C.
Risk was dependent on dose, background medications, and type of GLP-1 receptor agonist.
Timely administration of antibiotics was associated with a 30% reduction in 30 day mortality.
The ultimate goal should be to more closely regulate potentially injurious ingredients in herbal and dietary supplements.
The FDA issues a warning about the risk of hepatitis B virus reactivation among patients taking direct-acting antivirals to treat hepatitis C infections.
Biologic agents increase the risk of opportunistic infection, but do not increase the risk of serious infection or malignancy.
Physical Activity reduces intrahepatic lipid content and markers of hepatocellular injury in patients with NAFLD and this effect correlated with baseline body mass index.
Patients diagnosed with upper functional gastroenterology disorders often have irritable bowel syndrome
The risk factors for IBS-FD overlap deserve more concern, according to the authors.
The mortality rate from pancreatic cancer is significantly higher in the American region than in the European and Western Pacific regions.
Most cases of chronic pancreatitis in women are from nonalcoholic etiologies, according to researchers.
The USPSTF has released a recommendation statement regarding screening adults for colorectal cancer.
Using a stepwise approach to diagnose and treat gastrointestinal bleeding can improve patient outcomes.
When recommending probiotics to patients, NPs should remember that different strains have different health benefits.
Women with Crohn disease who use oral contraceptives for more than 1 year have an increased risk of surgery.
The FDA warns that the antidiarrheal loperamide can lead to serious cardiac events when taken in high doses.
High gluten intake during the first 2 years of life was associated with an increased risk of celiac disease during childhood.
A low-dose aspirin regimen was associated with a 3% lower risk of cancer overall.
Patients with Crohn disease who ate high-fiber foods were 40% less likely to have a disease flare.
Strong evidence for efficacy has been established for stimulant and osmotic laxatives, new intestinal secretagogues, and peripherally restricted μ-opiate receptor antagonists, according to a review in JAMA.
Naloxegol functions as a peripherally acting mu-opioid receptor antagonist in tissues such as the gastrointestinal tract, thereby decreasing the constipating effects of opioids.
Delphi methodology can optimize gastroenterology and hepatology workups.
The quality of colon cleansing is better with split-dose regimens than with day-before prep.
Patients with uncomplicated appendicitis may be treated with antibiotics instead of surgery.
Adults who took PPIs had a significantly higher risk of heart attack compared with those who didn't.
With metformin, mean score for gastrointestinal side effects higher for gastritis subjects over four weeks.
Increased levels of anxiety correlated with more severe retrosternal pain and burning among patients with gastroesophageal reflux disease (GERD).
Two new therapies to treat irritable bowel syndrome, eluxadoline and rifaximin, have been approved by the FDA.
At least 53 people in nine states have fallen ill, while 10 have been hospitalized, CDC officials report.
Safe hygiene practices can prevent norovirus outbreaks, according to the CDC.
C. difficile costs as much as $4.8 billion in estimated extra health care costs per year.
In recurrent infections caused by C. difficile, the intervention is successful 85% of the time.
Most of the patients had minor side effects. Nine of them developed serious health issues, but just three were considered related to the treatment.
More than two dozen of metabolites were highly correlated with diet, and about half the molecules had not previously been linked to obesity risk.
Colorectal cancer screening was higher in 2010 than in 2008 (58.9% versus 53.7%) and correlated with longer life expectancy and younger age.
The reduced risk was largely due to fewer cases of gastrointestinal cancers, including colon cancer, rectal cancer, and esophageal cancer.
In the United States, most Shigella is already resistant to the antibiotics ampicillin and trimethoprim/sulfamethoxazole.
All-oral simeprevir-sofosbuvir superior to interferon-based treatment for HCV patients with compensated cirrhosis
Patients assigned the interferon-containing regimen had a significantly higher rate of virologic relapse compared with patients given simeprevir and sofosbuvir.
The investigators also found that being overweight or obese boosts the chances of developing liver cancer.
Adding ledipasvir/sofosbuvir or sofosbuvir to amiodarone could cause symptomatic bradycardia, reported the FDA.
Increase in proportion of PPIs discontinued at hospital discharge after intervention implementation.
Screening children for five height- and weight-related differences in growth could be an effective means of spotting those with celiac disease.
In both cases, there were breaches in safety rules, CDC reports.
Overall survival was significantly improved for patients treated with nucleoside analogues (NAs) versus those who received no NAs.
The FDA has approved esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca's Nexium.
The prevalence of unhealthy dietary behaviors was higher among RFD and NRFD compared with healthy controls.
There was no difference overall in the incidence with different statins, but high-dose atorvastatin was associated with increased hospitalization.
Adiposity at age 3 years has been linked to diagnosis and severity of hepatic steatosis in late adolescence.
Levels of alkaline phosphatase that were two times the upper limit of normal at one year after study enrollment best predicted patient outcomes.
Ceftolozane/tazobactam is the fourth antibiotic to be FDA approved in 2014
Colonic propionate may aid in appetite suppression in overweight adult patients.
New guidelines for irritable bowel syndrome treatment have been released by the American Gastroenterological Association.